Back to Authors

Pospı́šilová, Šárka

https://orcid.org/0000-0001-7136-2680

A5071015212 | I1310815967

Mayo Clinic

Central European Institute of Technology

Citations 11

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Blood | January 29, 2015 | Volume: 125 | Issue: 5 | Pages: 856-859

10.1182/blood-2014-09-600874 | PMID 25634617

Key Points CLL stereotyped subset #2 (IGHV3-21/IGLV3-21) is uniformly aggressive independently of somatic hypermutation status. The prognosis for non–subset #2/IGHV3-21 CLL resembles that of the remaining CLL cases with similar somatic hypermutation status.